Cargando…
Neutrophil-lymphoycyte-ratio, platelet-lymphocyte-ratio and procalcitonin for early assessment of prognosis in patients undergoing VA-ECMO
The use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasing, but mortality remains high. Early assessment of prognosis is challenging and valid markers are lacking. This study aimed to investigate Neutrophil–Lymphocyte Ratio (NLR), Platelet-Lymphocyte-Ratio (PLR) and Procalc...
Autores principales: | Roth, Sebastian, M’Pembele, René, Stroda, Alexandra, Jansen, Catrin, Lurati Buse, Giovanna, Boeken, Udo, Akhyari, Payam, Lichtenberg, Artur, Hollmann, Markus W., Huhn, Ragnar, Aubin, Hug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752603/ https://www.ncbi.nlm.nih.gov/pubmed/35017601 http://dx.doi.org/10.1038/s41598-021-04519-7 |
Ejemplares similares
-
Fibrinogen–Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2021) -
Life impact of VA‐ECMO due to primary graft dysfunction in patients after orthotopic heart transplantation
por: M'Pembele, René, et al.
Publicado: (2021) -
Risk Factors for Acute Kidney Injury Requiring Renal Replacement Therapy after Orthotopic Heart Transplantation in Patients with Preserved Renal Function
por: M‘Pembele, René, et al.
Publicado: (2021) -
Validation of days alive and out of hospital as a new patient-centered outcome to quantify life impact after heart transplantation
por: M’Pembele, René, et al.
Publicado: (2022) -
Days alive and out of hospital after left ventricular assist device implantation
por: Roth, Sebastian, et al.
Publicado: (2022)